PROLONGATION OF CANINE SKIN GRAFT SURVIVAL BY DEOXYCOFORMYCINEPSTEIN RB; FEY T; SARPEL S et al.1982; TRANSPLANTATION; ISSN 0041-1337; USA; DA. 1982; VOL. 33; NO 2; PP. 208-209; BIBL. 10 REF.Article

ENHANCEMENT OF THE ANTITUMOR ACTIVITY OF ARABINOFURANOSYLADENINE BY 2'-DEOXYCOFORMYCINLEPAGE GA; WORTH LS; KIMBALL AP et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 4; PP. 1481-1485; BIBL. 11 REF.Article

BIOCHEMICAL PHARMACOLOGY AND TOXICOLOGY OF 8-AZAADENOSINE ALONE AND IN COMBINATION WITH 2'-DEOXYCOFORMYCIN (PENTOSTATIN)SPREMULLI EN; CRABTREE GW; DEXTER DL et al.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 14; PP. 2415-2421; BIBL. 22 REF.Article

EFFECTS OF 2'-DEOXYCOFORMYCIN INFUSION ON MOUSE ADENOSINE DESAMINASETEDDE A; BALIS ME; SCHONBERG R et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 8; PP. 3044-3050; BIBL. 37 REF.Article

ENHANCEMENT OF 9-BETA -D-ARABINOFURANOSYLADENINE CYTOTOXICITY TO MOUSE LEUKEMIA L1210 IN VITRO BY 2'-DEOXYCOFORMYCINCASS CE; AU YEUNG TH.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 4; PP. 1486-1491; BIBL. 25 REF.Article

THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIAPRENTICE HG; RUSSELL NH; LEE N et al.1981; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1981; NO 8258; PP. 1250-1254; BIBL. 22 REF.Article

2'-DEOXYCOFORMYCIN: A NEW ANTICANCER AGENTPOSTER DS; PENTA JS; BRUNO S et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 2; PP. 209-213; BIBL. 34 REF.Article

ENHANCEMENT OF THE BIOLOGICAL ACTIVITY OF CORDYCEPIN (3'-DEOXYADENOSINE) BY THE ADENOSINE DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCINJOHNS DG; ADAMSON RH.1976; BIOCHEM. PHARMACOL.; G.B.; DA. 1976; VOL. 25; NO 12; PP. 1441-1444; BIBL. 7 REF.Article

CLINICAL PHARMACOLOGY OF ARABINOFURANOSYLADENINE IN COMBINATION WITH DEOXYCOFORMYCINMAJOR PP; AGARWAL RP; KUFE DW et al.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 10; NO 2; PP. 125-128; BIBL. 23 REF.Article

CLINICAL PHARMACOLOGY OF DEOXYCOFORMYCINMAJOR PP; AGARWAL RP; KUFE DW et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 58; NO 1; PP. 91-96; BIBL. 20 REF.Article

2-DEOXYCOFORMYCIN INHIBITION OF INTRACELLULAR PHOSPHORYLATION OF ADENOSINE IN NOVIKOFF RAT HEPATOMA CELLSPLAGEMANN PGW; WOHLHUETER RM.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 5; PP. 417-426; BIBL. 25 REF.Article

EFFECTS OF 2'-DEOXYCOFORMYCIN INFUSION ON MOUSE PHOSPHORIBOSYL PYROPHOSPHATE SYNTHETASEYIP LC; TEDDE A; BALIS ME et al.1980; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1980; VOL. 29; NO 20; PP. 2888-2890; BIBL. 17 REF.Article

TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA WITH 2'-DEOXYCOFORMYCIN: CLINICAL AND BIOCHEMICAL CONSEQUENCES OF ADENOSINE DEAMINASE INHIBITIONKOLLER CA; MITCHELL BS; GREVER MR et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1949-1952; BIBL. 14 REF.Article

DEOXYADENOSINE TRIPHOSPHATE ACCUMULATION IN ERYTHROCYTES OF DEOXYCOFORMYCIN-TREATED MICESMITH CM; HENDERSON JF.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 8; PP. 1545-1551; BIBL. 36 REF.Article

TREATMENT OF LYMPHOID MALIGNANCIES WITH 2'-DEOXYCOFORMYCIN. A PILOT STUDYKANOFSKY JR; ROTH DG; SMYTH JF et al.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 2; PP. 179-183; BIBL. 12 REF.Article

EFFECT OF 2'-DEOXYCOFORMYCIN ON THE BIOLOGIC HALF-LIFE OF 9-BETA -D-ARABINOFURANOSYLADENINE 5'-TRIPHOSPHATE IN CHO CELLSSHEWACH DS; PLUNKETT W.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 15; PP. 2401-2404; BIBL. 28 REF.Article

ALTERATIONS IN ERYTHROCYTE, ADENINE NUCLEOTIDE POOLS RESULTING FROM 2'-DEOXYCOFORMYCIN THERAPY = MODIFICATIONS DES POOLS D'ADENINE NUCLEOTIDES ERYTHROCYTAIRES APRES UN TRAITEMENT PAR 2'-DESOXYCOFORMYCINEKOLLER CA; MITCHELL BS.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1409-1414; ABS. ENG; BIBL. 30 REF.; GRAPHArticle

CLINICAL PHARMACOLOGY OF 9-BETA -D-ARABINOFURANOSYLADENINE IN COMBINATION WITH 2'-DEOXYCOFORMYCINAGARWAL RP; BLATT J; MISER J et al.1982; CANCER RES.; USA; DA. 1982; VOL. 42; NO 9; PP. 3884-3886; BIBL. 13 REF.Article

2'-DEOXYCOFORMYCIN (DCF) AND 9-BETA -D-ARABINOFURANOSYLADENINE (ARA-A) IN THE TREATMENT OF REFRACTORY ACUTE MYELOCYTIC LEUKEMIAGRAY DP; GREVER MR; SIAW MFE et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 253-257; BIBL. 8 REF.Article

PHYSIOLOGIC MODEL FOR THE PHARMACOKINETICS OF 2' DEOXYCOFORMYCIN IN NORMAL AND LEUKEMIC MICEKING FG; DEDRICK RL.1981; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1981; VOL. 9; NO 5; PP. 519-534; BIBL. 24 REF.Article

TOXICITY AND IMMUNOSUPPRESSIVE ACTIVITY OF BINARY COMBINATIONS OF 2'-DEOXYCOFORMYCIN AND 2'-DEOXYADENOSINEPAINE RM; WESTON BJ; CLINK HM et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 259-266; BIBL. 31 REF.Article

THE EFFECT OF NUCLEOSIDES AND DEOXYCOFORMYCIN ON ADENOSINE AND DEOXYADENOSINE INHIBITION OF HUMAN LYMPHOCYTE ACTIVATIONUBERTI J; LIGHTBODY JJ; JOHNSON RM et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 1; PP. 189-193; BIBL. 32 REF.Article

LEVELS OF ADENOSINE DEAMINASE IN SOME EXPERIMENTAL ANIMAL TUMOURS AND THE POSSIBLE THERAPEUTIC EFFECT OF THE ADA INHIBITOR 2-DEOXY-COFORMYCINHALL JG; GYURE L; PEPPARD J et al.1979; BRIT. J. CANCER; GBR; DA. 1979; VOL. 40; NO 5; PP. 750-754; BIBL. 22 REF.Article

THE CLINICAL PHARMACOLOGY OF THE ADENOSINE DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCINSMYTH JF; PAINE RM; JACKMAN AL et al.1980; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1980; VOL. 5; NO 2; PP. 93-101; BIBL. 27 REF.Article

EFFECTS OF 2'-DEOXYCOFORMYCIN, 9-BETA -D-ARABINOFURANOSYLADENINE 5'-PHOSPHATE AND 1-BETA -D-ARABINOFURANOSYLCYTOSINE TRIPLE COMBINATION THERAPY ON INTRACEREBRAL LEUKEMIA 1210.CARON N; LEE SH; KIMBALL AP et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 9; PP. 3274-3279; BIBL. 28 REF.Article